Hybrigenics SA, a French drug discovery company focused on oncology, has appointed William Vickery to the newly created post of head of corporate and business development.
Mr Vickery previously worked for ExonHit Therapeutics as a director of business development. Before that, he was a director of business development at Roche Pharmaceuticals in the United States where he had responsibility for out-licensing and divestiture.
Copyright 2010 Evernow Publishing Ltd